Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIDENT triple-pill trial for recurrent stroke prevention after intracerebral hemorrhage
2016-003724-23Phase 3Completed
- Sponsor
- The George Institute for Global Health
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of telmisartan, amlodipine and indapamide in intracerebral hemorrhage (ICH) and stroke (2 arms), sponsored by The George Institute for Global Health. Started Oct 2017; status: completed.
02
Drugs
telmisartanamlodipineindapamide
03
Conditions
intracerebral hemorrhage (ICH)stroke
Beyond the preview
Go deeper on 2016-003724-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003724-23.